Journal of Mosquito Research 2024, Vol.14, No.4, 215-225 http://emtoscipublisher.com/index.php/jmr 225 Silva J., Lopes T., Oliveira-Filho E., Oliveira R., Durães-Carvalho R., and Gil L., 2018, Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, zika and chikungunya viruses, Acta Tropica, 182: 257-263. Teramoto T., Huang, X., Armbruster, P., & Padmanabhan, R. (2019). Infection of Aedes albopictus Mosquito C6/36 Cells with the wMelpop Strain of Wolbachia Modulates Dengue Virus-Induced Host Cellular Transcripts and Induces Critical Sequence Alterations in the Dengue Viral Genome. Journal of Virology, 93: 19-37. https://doi.org/10.1128/JVI.00581-19 Trovato M., Sartorius R., D’Apice L., Manco R., and Berardinis P., 2020, Viral emerging diseases: challenges in developing vaccination strategies, Frontiers in Immunology, 11: 13-15. https://doi.org/10.3389/fimmu.2020.02130 Wang D.W., 2024, Malaria control: advances in vector management and vaccine development, Journal of Vaccine Research, 14(2): 85-94. Weissenböck H., Hubálek Z., Bakonyi T., Bakonyi T., and Nowotny N., 2010, Zoonotic mosquito-borne flaviviruses: worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases, Veterinary Microbiology, 140(4): 271-280. https://doi.org/10.1016/j.vetmic.2009.08.025 Whitehead S., Durbin A., Pierce K., Elwood D., McElvany B., Fraser E., Carmolli M., Tibery C., Hynes N., Jo M., Lovchik J., Larsson C., Doty E., Dickson D., Luke C., Subbarao K., Diehl S., and Kirkpatrick B., 2017, In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination, PLoS Neglected Tropical Diseases, 11: 87-89. https://doi.org/10.1371/journal.pntd.0005584 Yang Z., Bogdan P., and Nazarian S., 2020, An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study, Scientific Reports, 11: 8-19. https://doi.org/10.1038/s41598-021-81749-9
RkJQdWJsaXNoZXIy MjQ4ODY0NQ==